VISQUE DPS CE IVDR Certified: Revolutionizes Digital Pathology

Visque DPS

VISQUE DPS: A Game Changer in Digital Pathology

Slide scanners like the VISQUE DPS are revolutionizing digital pathology. Vieworks has announced that their slide scanner, the VISQUE DPS, now has the CE IVDR certification for in vitro diagnostic medical devices. This certification allows Vieworks to distribute in European markets, a major step forward in digital pathology.

Understanding the VISQUE DPS Certification

The VISQUE DPS went through rigorous certification processes following new European regulations introduced in May 2022. These regulations added several compliance requirements:

  • Enhanced technical documentation.
  • Mandatory clinical performance evaluation reports.
  • Compulsory post-market surveillance reporting.

Vieworks met these requirements to ensure the VISQUE DPS not only performs well but also maintains a high level of trust and reliability.

VISQUE DPS Features

The VISQUE DPS slide scanner boasts state-of-the-art technology:

  • High-resolution whole slide imaging (WSI).
  • Fast scanning speeds.
  • Reliable performance for both tissue and cytology examinations.

Key Technical Advances

  1. Realtime Extended Focus Mode:
    • Uses a self-developed high-resolution camera.
    • Captures three images at different focal points in one scan.
    • Selectively composites clear image areas for the best results.
  2. Fast Processing:
    • Holds up to 510 tissue slides at once.
    • Can generate 83 WSI slides (15x15mm) per hour.
  3. Adaptability:
    • Integrates specific requirements from pathology experts.
    • Designed in response to input from leading hospital professionals.

VISQUE DPS In The Market

The launch of VISQUE DPS in Europe positions Vieworks to grow beyond the domestic and North American markets. This step follows successful product trials in major hospitals and positive feedback from the USCAP Annual Meeting 2025 in Boston.

Vieworks sees the VISQUE DPS as a vital component in its strategy to expand within the bio-field sector, expecting it to enhance their market share.

Future Outlook

Vieworks aims to capitalize on its European certification to:

  • Establish VISQUE DPS as a leader in digital pathology.
  • Strengthen its presence in both North American and European markets.
  • Drive innovation in digital pathology with high-performance products.

By meeting stringent European standards, Vieworks hopes to ensure their products align with the needs of top medical facilities globally. If you’re interested in digital pathology, the VISQUE DPS represents significant advancements in precision and efficiency.

Scroll to Top